🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Blood-based tumor mutational burden as a predictive marker for immune checkpoint inhibitors in #ProstateCancer. #bTMB may not be a reliable predictor for #Immunotherapy in #ProstateCancer & #BreastCancer. New data from a multi-institutional study suggest bTMB ≠ tissue TMB. More

Triplet therapy in #KidneyCancer: Insights from #COSMIC313 and the path forward. Laurence Albiges Gustave Roussy joins Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr to discuss COSMIC-313 trial final overall survival results and how these findings might inform future trial designs, including unblinded studies and

INCMNSZ we were happy to receive Pedro C Barata, MD MSc FACP to discuss about #ProstateCancer 👨🏻‍⚕️👩🏻‍⚕️🌍🇲🇽 Multidisciplinary discussion w Urology, Genetics and pathology 📘🖇️🗂️💙 José Luis Rodríguez Sofía Elias

So happy to share beyond GU Onc, trials and the future of prostate cancer treatment with Pedro C Barata, MD MSc FACP, he’s a true mentor and incredible human being. Welcome back to Mexico whenever you want 🤝🤝 🇲🇽🍣🍱

So excited to kick off the first episode of our new podcast: ASCO Education: By the Book with good friend and former #EdBook editor Don Dizon! ASCO ascoeducation.libsyn.com/the-evolution-…

Thanks to Nathan A. Pennell MD, PhD, FASCO Pedro C Barata, MD MSc FACP Hope Rugo for the invite!

Erika Hamilton, MD ASCO Cardinale B. Smith Robin Zon, MD, FACP, FASCO Journal of Clinical Oncology Thanks for the shout out Erika Hamilton, MD ! Thanks to the ASCO Ed leadership for the invite & brilliantly selecting the authors Cardinale B. Smith Nathan A. Pennell MD, PhD, FASCO Pedro C Barata, MD MSc FACP Hope Rugo Robin Zon, MD, FACP, FASCO Got to work and collaborate with an amazing multi-disciplinary group of colleagues & learned a

Excelente plática con Pedro C Barata, MD MSc FACP Francisco Rodríguez-Covarrubias en INCMNSZ Instituto Nacional de Cancerología Oscar Arrieta Paula Cabrera Actualización TALAPRO-2: talazo+enza vs enza demostró… 🟨 Beneficio en SLPr y SG en pacientes no seleccionados (cohorte 1) 🟩 Beneficio en SLPr y SG en pacientes HRD (cohorte 2)

#CALYPSO trial: Savolitinib and durvalumab in advanced papillary #RenalCancer. Francesca Jackson-Spence Barts Experimental Cancer Medicine Centre joins Pedro C Barata, MD MSc FACP Case Comp Cancer Ctr to discuss final overall survival data and circulating tumor DNA analysis for patients with advanced papillary renal cancer in the CALYPSO

Novel hormonal agents in men with #mCRPC and reduced performance status: Experiences of a specialized single center. #mCRPC in frail patients (ECOG ≥2) challenges NHA benefits. A single-center study found no OS advantage with enzalutamide/abiraterone vs. best supportive care.

Congrats to super mentee Dimitra R. Bakaloudi MD, MS, MPA who led this so relevant study working with me & fantastic mentees & colleagues! Ali Khaki Rafee Talukder Vadim Koshkin MD joaquim bellmunt Shilpa Gupta Yousef Zakharia Daniel Castellano Rana McKay, MD, FASCO Pedro C Barata, MD MSc FACP DrTylerStewart Umang Swami Jason Brown

⭐️Feeling incredibly grateful and touched! One of my amazing patients surprised me today with zebra🦓 socks after reading my ASCO Educational book chapter on, "Designing Clinical Trials for Patients With Rare Cancers: Connecting the Zebras." 🦓Journal of Clinical Oncology 🦓 👍🏼Her thoughtful

My Captain! 🫡

Combination lenvatinib-tislelizumab for fumarate hydratase-deficient #RenalCellCarcinoma. Promising results for FH-deficient #RCC! Dr. Wen Kong shares data on #lenvatinib + #tislelizumab in 1L treatment—90% ORR, 20% CRs, and universal tumor shrinkage. Could TKI-IO combos

Awesome time spent at Amer. Urol. Assn. with colleagues talking about prostate cancer Alicia Morgans, MD, MPH #LasVegas Lee Ponsky University Hospitals

Okay. This photo in the SWOG Cancer Research Network meeting lobby totally made my day! It's the 25th anniversary of the The Hope Foundation for Cancer Research-hosted #YITC. Check out all the amazing folks that have been thru the course since Day 1. I spy Neeraj Agarwal, MD, FASCO, Parminder singh, H. Jack West, MD, FASCO, Syed A. Ahmad, Reshma Jagsi,

Driving Knowledge to Action: Building a Better Future With Artificial Intelligence–Enabled Multidisciplinary Oncology | American Society of Clinical Oncology Educational Book ascopubs.org/doi/full/10.12… #ASCO25 #EdBook

Busy morning SWOG Cancer Research Network #GUonc mtg for me & fellow #patientadvocate Darrell Nakagawa. As the #kidneycancer & #bladdercancer #patientadvocates, we’re here representing our fellow patients in #clinicaltrial dev. Thanks to The Hope Foundation for Cancer Research & the GU committee for empowering & including us!

Watch as Pedro C Barata, MD MSc FACP, Moshe Ornstein MD, Elizabeth Wulff-Burchfield, MD, and Katy Beckermann discuss the 8-year follow-up from CheckMate 214, evaluating nivolumab plus ipilimumab for first-line treatment of advanced #RCC Watch more here: hubs.li/Q03l73dr0

Join us for the GUARD Symposium🇪🇸 featuring interactive workshops where experts collaboratively discuss real-world genitourinary cancer cases. REGISTER👉 events.tacticsmd.net/guard-internat… FREE VIRTUAL Admission for LMIC's & LATAM Colleagues Designed by GUARD Consortium for oncology